HROW peer analysis
Harrow (HROW) against its competitors: price, today's move, 1-year return and market value side by side.
HROW and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLCO Bausch + Lomb | $20.01 | 0.05% | 33.94% | – |
| EYPT EyePoint | $0.37 | 7.58% | -97.14% | $30.04M |
| KOD Kodiak Sciences | $97.62 | -1.57% | 438.62% | $6.23B |
| OCS Oculis | $7.71 | -6.66% | -60.01% | – |
| OCUL Ocular Therapeutix | $6.90 | 2.53% | -40.82% | $1.53B |
| OTLK Outlook Therapeutics | $0.47 | 0.23% | -62.76% | $113.96M |
| TARS Tarsus | $73.32 | -2.04% | 6.55% | – |
| TTRX Turn Therapeutics | $9.65 | -7.48% | 98.97% | – |
| HROW Harrow | $28.20 | -0.14% | -25.34% | $1.06B |
- HROW's peers: BLCO (Bausch + Lomb), EYPT (EyePoint), KOD (Kodiak Sciences), OCS (Oculis), OCUL (Ocular Therapeutix), OTLK (Outlook Therapeutics), TARS (Tarsus), TTRX (Turn Therapeutics).
Updated 2026-11-03 11:33 UTC